NO975682L - Pyridiniminyl-1,2-benzisoxazoler og -benzisothiazoler som anti-psykotiske midler - Google Patents

Pyridiniminyl-1,2-benzisoxazoler og -benzisothiazoler som anti-psykotiske midler

Info

Publication number
NO975682L
NO975682L NO975682A NO975682A NO975682L NO 975682 L NO975682 L NO 975682L NO 975682 A NO975682 A NO 975682A NO 975682 A NO975682 A NO 975682A NO 975682 L NO975682 L NO 975682L
Authority
NO
Norway
Prior art keywords
benzisoxazoles
benzisothiazoles
pyridiniminyl
psychotic agents
intermediates
Prior art date
Application number
NO975682A
Other languages
English (en)
Other versions
NO975682D0 (no
Inventor
David M Fink
Barbara E Kurys
Gregory M Shutske
Iv John D Tomer
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1996/007319 external-priority patent/WO1996039405A1/en
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO975682D0 publication Critical patent/NO975682D0/no
Publication of NO975682L publication Critical patent/NO975682L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Nye pyridiniminyl-l,2-benzisoxazoler og -benzisotiazoler, mellomprodukter og fremgangsmåter for fremstillingen derav, og metoder for lindring av hukommelses- dysfunksjon og behandling av depresjon under anvendelse av 1,2-benzisoxazoler og -benzisotiazoler og mellomprodukter, eller preparater derav er beskrevet.
NO975682A 1995-06-06 1997-12-05 Pyridiniminyl-1,2-benzisoxazoler og -benzisothiazoler som anti-psykotiske midler NO975682L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46602195A 1995-06-06 1995-06-06
US08/637,091 US5668154A (en) 1995-06-06 1996-05-02 Pyridiniminyl-1,2-benzisoxazoles and -benzisothiazoles
PCT/US1996/007319 WO1996039405A1 (en) 1995-06-06 1996-05-14 Pyridiniminyl-1,2-benzisoxazoles and- benzisothiazoles as antipsychotic agents

Publications (2)

Publication Number Publication Date
NO975682D0 NO975682D0 (no) 1997-12-05
NO975682L true NO975682L (no) 1998-02-05

Family

ID=23850131

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975682A NO975682L (no) 1995-06-06 1997-12-05 Pyridiniminyl-1,2-benzisoxazoler og -benzisothiazoler som anti-psykotiske midler

Country Status (17)

Country Link
US (3) US5668154A (no)
EP (1) EP0848713B1 (no)
KR (1) KR100309215B1 (no)
AR (1) AR002204A1 (no)
AT (1) ATE197153T1 (no)
AU (1) AU708843B2 (no)
CA (1) CA2224171A1 (no)
DE (1) DE69610778T2 (no)
DK (1) DK0848713T3 (no)
ES (1) ES2153584T3 (no)
GR (1) GR3035249T3 (no)
HU (1) HUP9802571A3 (no)
NO (1) NO975682L (no)
NZ (1) NZ308831A (no)
PT (1) PT848713E (no)
TW (1) TW355710B (no)
ZA (1) ZA964565B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083932A (en) * 1997-04-18 2000-07-04 Cv Technologies Inc. Pharmaceutical compositions derived from ginseng and methods of treatment using same
GT199900185A (es) 1998-11-06 2001-04-18 Novedosa pirimidin-4-enamina como fungicida.
US6123554A (en) * 1999-05-28 2000-09-26 Berg Technology, Inc. Connector cover with board stiffener
US9907751B2 (en) * 2016-03-10 2018-03-06 RxOMEG Therapeutics LLC Composition and method of use of colchicine oral liquid
US10226423B1 (en) 2017-12-20 2019-03-12 RxOMEG Therapeutics LLC Colchicine drug-to-drug interactions
CN110117278B (zh) * 2018-02-07 2022-07-19 石家庄以岭药业股份有限公司 烷氧基苯并五元(六元)杂环胺类化合物及其药物用途
WO2023083445A1 (en) 2021-11-10 2023-05-19 Symrise Ag Compositions comprising trpm8 agonistic cooling agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5328920A (en) * 1991-04-17 1994-07-12 Hoechst-Roussel Pharmaceuticals Incorporated Substituted (pyridinylamino)-indoles
US5177088A (en) * 1991-04-17 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Substituted 3-(pyridinylamino)-indoles
US5494908A (en) * 1992-11-23 1996-02-27 Hoechst-Roussel Pharmaceutical Incorporated Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds

Also Published As

Publication number Publication date
DK0848713T3 (da) 2000-12-18
CA2224171A1 (en) 1996-12-12
ZA964565B (en) 1996-12-12
ES2153584T3 (es) 2001-03-01
US5728717A (en) 1998-03-17
AU708843B2 (en) 1999-08-12
MX9709450A (es) 1998-06-28
KR100309215B1 (ko) 2001-12-28
KR19990022265A (ko) 1999-03-25
AR002204A1 (es) 1998-01-07
EP0848713B1 (en) 2000-10-25
HUP9802571A2 (hu) 1999-08-30
DE69610778D1 (de) 2000-11-30
GR3035249T3 (en) 2001-04-30
US5668154A (en) 1997-09-16
EP0848713A1 (en) 1998-06-24
AU5867796A (en) 1996-12-24
DE69610778T2 (de) 2001-06-13
TW355710B (en) 1999-04-11
US5948798A (en) 1999-09-07
NO975682D0 (no) 1997-12-05
HUP9802571A3 (en) 1999-11-29
PT848713E (pt) 2001-02-28
NZ308831A (en) 1998-11-25
ATE197153T1 (de) 2000-11-15

Similar Documents

Publication Publication Date Title
NO20002788D0 (no) Nye forbindelser
TR199901174T2 (xx) Yeni heterosiklilmetil-ikameli pirazol t�revleri.
TR199802676A2 (xx) T�m�rlerin, t�m�rle ilgili hastal�klar�n ve ka�eksinin tedavisi ve �nlenmesi i�in y�ntem.
DK0966447T3 (da) Anvendelige små molekyler til behandling af betændelsessygdomme
NO20002787L (no) Nye forbindelser
AU5799294A (en) Isoxazole-4-carboxamides and hydroxy-alkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use
TR199700726T1 (xx) Farnezil transferaz �nleyiciler ve m�stahzarlar�.
DK0630228T3 (da) Middel til regulering af hudens fedtethed
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
TR200002773T2 (tr) Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı.
ES2194989T3 (es) Composicion adminstrada por via oral, que comprende una toxina de zonula occludens y un agente que tiene una actividad biologica, y su utilizacion.
NO972451L (no) Heterosyklyloksy- og tiometyl-1,2,5-tiadiazolidin-3-on 1,1-dioksyder og preparater og fremgangsmåte for anvendelse derav
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
NO971625L (no) Nye peptider med immunomodulatoriske effekter
HUP0004795A2 (hu) Univerzálisan alkalmazható vérplazma
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
NO975682L (no) Pyridiniminyl-1,2-benzisoxazoler og -benzisothiazoler som anti-psykotiske midler
FI974640A (fi) Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit
DE68918944D1 (de) Künstliche rezeptor-analoge.
MX9101958A (es) Inhibidores de acat de urea de aminosulfonilo
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
NO20000519L (no) 2-acylaminopropanaminer som takykininreseptorantagonister
NO982100L (no) Peptid-derivater av Dolastatin 15 og deres anvendelse
NO993180L (no) N-(pyridinylamino)isoindoler og beslektede forbindelser
MX9603516A (es) Derivados de oxima y su uso como pesticidas.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application